Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease

Journal of Experimental Medicine

Volumn 183, Issue 2, 1996, Pages 657-661

  Braun, Michel Y ^a   Lowin, Bente ^a   French, Lars ^b   Acha Orbea, Hans ^a   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD3 ANTIGEN; FAS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PERFORIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; IRRADIATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; BASE SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PORE FORMING CYTOTOXIC PROTEINS; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030050453     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.2.657     Document Type: Article

References (36)

1. Berke, G. 1995. The CTL's kiss of death. Cell. 81:9-12.
2. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature (Lond.). 370:650-652.
3. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity Science (Wash. DC). 265:528-530.
4. Walsh, C.M., M. Matloubian, C.C. Liu, R. Ueda, C.G. Kurahara, J.L. Chnstensen, M.T. Huang, J.D. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA. 91: 10854-10858.
5. Lowin, B., M.C. Peitsch, and J. Tschopp. 1995. Perform and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 198:1-23.
6. Heusel, J.W., R.L. Wesselschmidt, S. Shresta, J.H. Russell, and T.J. Ley. 1994. Cytotoxic lymphocytes require granzyme-B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76:977-987.
7. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
8. Watanabe, F.R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
9. Ware, C.F., T.L. VanArsdale, P.D. Crowe, and J.L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 126:175-217.
10. Nagata, S. 1994. Mutations, in the Fas antigen gene in lpr mice. Semin. Immunol. 6:3-8.
11. Vogelsang, G.B., and A.D. Hess. 1994. Graft-versus-host disease: new directions for a persistent problem. Blood. 84:2061-2067.
12. Sprent, J. 1993. Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin. Immunol. 5:187-194.
13. Santos, G.W., G.W. Hess, and G.B. Vogelsang. 1985. Immunol. Rev. 88:169-192.
14. Ferrara, J.L., and H.J. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667-674.
15. Ferrara, J.L. 1993. Cytokine dysregulation as a mechanism of graft versus host disease. Curr. Opin. Immunol. 5:794-799.
16. Lowin, B., F. Beermann, A. Schmidt, and J. Tschopp. 1994. A null mutation in the perform gene impairs cytolytic T lymphocyte- and NK-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:11151-11575.
17. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
18. Lynch, D.H., L.M. Watson. M.R. Alderson, P.R. Baum, R.E. Miller, T.W. Tough, M. Gibson, T. Davis-Smith, C.A. Smith, G. Hunter, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:131-136.
19. Roths, J.B., E.D. Murphy, and E.M. Eicher. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1-20.
20. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, et al. 1994. Two distinct pathways of specific killing revealed by perform mutant cytotoxic T cells. Immunity. 1:357-364.
21. Fiers, W. 1991. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS (Fed. Eur. Biochem. Soc.) Lett. 285:199-212.
22. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. i:355-357.
23. Piguet, F.F., G.E. Grau, B. Allet, and P. Vassalli, 1987. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166:1280-1289.
24. Grau, G.E., L.F. Fajardo, P.F. Piguet, B. Allet, P.H. Lambert, and P. Vassalli, 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (Wash. DC). 237:1210-1212.
25. Andersson, M., H. Gunne, B. Agerberth, H.G. Boman, T. Bergman, R. Sillard, H. Jörnvall, V. Mutt, B. Olsson, H. Wigzell, et al. 1995. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and tumor activity. EMBO (Eur. Mol. Biol. Organ.) J. 14:1615-1625.
26. Grebe, S.C., and J.W. Streilein. 1976. Graft-vs-host disease. Adv. Immunol. 22:119-221.
27. Bennett, M. 1987. Biology and genetics of hybrid resistance. Adv. Immunol. 41:333-445.
28. + cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts. Immunogenetics. 31:161-168.
29. Kagi, D., B. Ledermann, K Burki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-dencient mice. Nature (Lond.). 369:31-37.
30. Russell, J.H., B. Rush, C. Weaver, and R. Wang, 1993. Mature T cells of the autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA. 90: 4409-4413.
31. Ogasawara, J., F.R. Watanabe, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata, 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.). 364:806-809.
32. Chu, J.L , P. Ramos, A. Rosendorff, J. Nikolić-Žugić, E. Lacy, A. Matsuzawa, and K.B. Elkon. 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393-398.
33. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO (Eur. Mol. Biol. Organ.) J. 14:12-18.
34. Theofilopoulos, A.N., R.S. Balderas, Y. Gozes, M.T. Aguado, L.M. Hang, P.R. Morrow, and F.J. Dixon. 1985. Association of lpr gene with graft-vs.-host disease-like syndrome. J. Exp. Med. 162:1-18.
35. +-dependent receptor molecule for lymphocyte perforin. Nature (Lond.). 337:272-274.
36. Schulz, M., H.J. Schuurman, J. Joergensen, C. Steiner, T. Merloo, D. Kägi, H. Hengartner, R. Zinkernagel, M. Schreier, K. Bürki, and B. Ledermann. 1995. Acute rejection of vascular heart allografts by perforin deficient mice. Eur. J. Immunol. 25:474-480.